February 2019 tender notification
PHARMAC has resolved to award tenders for Sole Subsidised Supply Status and Hospital Supply Status for some products included in the 2018/19 Invitation to Tender, dated 1 November 2018.
Some of the pharmaceuticals that will be delisted when the period of Sole Subsidised Supply/Hospital Supply Status commences may be subject to existing listing contracts with PHARMAC. Suppliers of pharmaceuticals that are subject to such contracts should continue to supply their pharmaceuticals under those contracts. PHARMAC will continue to subsidise those pharmaceuticals accordingly until such time as those pharmaceuticals are delisted.
Notification of Product Changes (NOPC) forms, Containered Trade Product Pack (CTPP) codes and Pharmacodes
Please note that for any changes (price change, pack size change, new listing etc) to be effective in the Pharmaceutical Schedule (including Section H), suppliers are required to notify any changes to PHARMAC and the Pharmacy Guild of New Zealand by 4pm on the 12th of the month prior to the date of subsidy change. More information and NOPC forms can be found on our website.
Suppliers are required to ensure that a Pharmacode has been obtained from the Pharmacy Guild of New Zealand(external link) and that a CTPP code has been obtained from the New Zealand Universal List of Medicines(external link). Pharmacodes and CTPP codes must be provided to PHARMAC by the 5th of the month prior to the date of listing, or 10 business days following the market notification date (whichever is earliest). PHARMAC cannot list a product (and pharmacies cannot claim) without the correct Pharmacode.
2017/18 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2021
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
CORRECTION to January 2019 tender notification: in bold and strikethrough
1. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current pack price |
New pack price |
Sole supply brand (Supplier) | Date of listing | Date of reference pricing of other listed brands | Sole Subsidised Supply date | Brand (Supplier) affected by reference pricing and delisting |
|---|---|---|---|---|---|---|---|---|
| Zoledronic acid1 | Inj 4 mg per 5 ml, vial, 1 inj pack |
$84.50 |
$38.03 |
Zoledronic Acid Mylan (Mylan) |
1 March 2019 | 1 May 2019 | 1 August 2019 | Zometa (Novartis) |
|
1 Access is unchanged |
||||||||
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
2. Tenders awarded to pharmaceuticals where at least one other brand is listed.
The decisions were as follows:
| Chemical name | Presentation; Pack size and type |
Current pack price | New pack price | Hospital supply brand (Supplier) | DV Limit | Listing date | Hospital Supply Status date | Brand (Supplier) affected by delisting |
|---|---|---|---|---|---|---|---|---|
| Zoledronic acid2 | Inj 4 mg per 5 ml, vial 1 inj pack |
$84.50 |
$38.03 |
Zoledronic Acid Mylan (Mylan) |
1% | 1 March 2019 | 1 May 2019 | Zometa (Novartis) |
|
2 Access is unchanged |
||||||||
2018/19 Tender – Sole Subsidised Supply Status or Hospital Supply Status applies until 30 June 2022
Community pharmaceutical tenders – Section B of the Pharmaceutical Schedule
1. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
Current |
New |
Sole supply brand |
Date of subsidy change |
Sole Subsidised Supply date |
|---|---|---|---|---|---|---|
|
Aciclovir |
Tab dispersible 200 mg, 25 tablet, blister pack |
$1.60 |
$1.60 |
Lovir |
1 July 2019 |
1 October 2019 |
|
Aciclovir |
Tab dispersable 400 mg, 56 tablet blister pack |
$5.38 |
$5.38 |
Lovir |
1 July 2019 |
1 October 2019 |
|
Aciclovir |
Tab dispersible 800 mg, 35 tablet, blister pack |
$5.98 |
$5.98 |
Lovir |
1 July 2019 |
1 October 2019 |
|
Aspirin |
Tab 100 mg, 990 tablet, blister pack |
$12.50 |
$10.80 |
Ethics Aspirin EC (Multichem) |
1 August 2019 |
1 November 2019 |
|
Aspirin |
Tab dispersible 300 mg, 100 tablet, blister pack |
$3.90 |
$4.50 |
Ethics Aspirin (Multichem) |
1 July 2019 |
1 October 2019 |
|
Calcitriol |
Cap 0.5 mcg, 100 capsule, bottle pack |
$18.39 |
$13.75 |
Calcitriol-AFT (AFT) |
1 July 2019 |
1 October 2019 |
|
Calcitriol |
cap 0.25 mcg, 100 capsule, bottle pack |
$9.95 |
$7.95 |
Calcitriol-AFT (AFT) |
1 July 2019 |
1 October 2019 |
|
Cefaclor monohydrate |
Cap 250 mg, 100 capsule, bottle |
$24.70 |
$24.70 |
Ranbaxy-Cefaclor |
1 July 2019 |
1 October 2019 |
|
Cefaclor monohydrate |
Grans for oral liq 125 mg per 5 ml, |
$3.53 |
$3.53 |
Ranbaxy-Cefaclor |
1 July 2019 |
1 October 2019 |
|
Chlortalidone [chlorthalidone] |
Tab 25 mg, 50 tablet, bottle pack |
$8.00 |
$6.50 |
Hygroton (AFT) |
1 September 2019 |
1 December 2019 |
|
Dimethicone |
Crm, 5% pump bottle, 500 ml OP |
$4.59 |
$4.48 |
healthE Dimethicone 5% (Jaychem) |
1 July 2019 |
1 October 2019 |
|
Dimethicone |
Ltn 4%, 200 ml OP |
$4.98 |
$4.98 |
healthE Dimethicone |
1 July 2019 |
1 October 2019 |
|
Dipyridamole |
Tab long-acting 150 mg, 60 tablet, |
$11.52 |
$10.90 |
Pytazen SR (Douglas) |
1 July 2019 |
1 October 2019 |
|
Erythromycin (as lactobionate) |
Inj 1 g vial, 1 vial pack |
$16.00 |
$10.00 |
Erythromycin IV (AFT) |
1 September 2019 |
1 December 2019 |
|
Etoposide |
Cap 50 mg, 20 capsule, blister |
$340.73 |
$340.73 |
Vepesid |
1 April 2019 |
1 July 2019 |
|
Etoposide |
Cap 100 mg, 10 capsule, blister |
$340.73 |
$340.73 |
Vepesid |
1 April 2019 |
1 July 2019 |
|
Furosemide [frusemide] |
Inj 10 mg per ml, 2 ml ampoule, 5 |
$1.20 |
$1.15 |
Frusemide-Claris
(Baxter) |
1 July 2019 |
1 October 2019 |
|
Glycerin with sodium saccharin |
Suspension, 473 ml bottle |
$32.50 |
$30.95 |
Ora-Sweet SF (Midwest) |
1 April 2019 |
1 July 2019 |
|
Glycerin with sucrose |
Suspension, 473 ml bottle |
$32.50 |
$30.95 |
Ora-Sweet (Midwest) |
1 April 2019 |
1 July 2019 |
|
Haloperidol |
Inj 5 mg per ml, 1 ml ampoule, 10 |
$21.55 |
$21.55 |
Serenace |
1 July 2019 |
1 October 2019 |
|
Haloperidol |
Oral liq 2 mg per ml, 100 ml |
$23.84 |
$23.84 |
Serenace |
1 July 2019 |
1 October 2019 |
|
Haloperidol |
Tab 500 mcg, 100 tablet, bottle pack |
$6.23 |
$6.23 |
Serenace |
1 July 2019 |
1 October 2019 |
|
Haloperidol |
Tab 1.5 mg, 100 tablet, bottle pack |
$9.43 |
$9.43 |
Serenace |
1 July 2019 |
1 October 2019 |
|
Haloperidol |
Tab 5 mg, 100 tablet, bottle pack |
$29.72 |
$29.72 |
Serenace |
1 July 2019 |
1 October 2019 |
|
Levetiracetam* |
Tab 250 mg, 60 tablet, blister pack |
$24.03 |
$4.99 |
Everet (Rex Medical) |
1 May 2019 |
1 August 2019 |
|
Levetiracetam* |
Tab 500 mg, 60 tablet, blister pack |
$28.71 |
$8.79 |
Everet (Rex Medical) |
1 May 2019 |
1 August 2019 |
|
Levetiracetam* |
Tab 750 mg, 60 tablet, blister pack |
$45.23 |
$14.39 |
Everet (Rex Medical) |
1 May 2019 |
1 August 2019 |
|
Levetiracetam* |
Tab 1,000 mg, 60 tablet, blister pack |
$59.12 |
$18.59 |
Everet (Rex Medical) |
1 May 2019 |
1 August 2019 |
|
Lidocaine [lignocaine] hydrochloride |
Inj 1%, 20 ml vial, 5 vials |
$12.00 |
$6.20 |
Lidocaine-Claris (Baxter) |
1 April 2019 |
1 July 2019 |
|
Lidocaine [lignocaine] hydrochloride |
Inj 2%, 20 ml vial, 5 vials |
$12.00 |
$6.45 |
Lidocaine-Claris (Baxter) |
1 April 2019 |
1 July 2019 |
|
Loperamide hydrochloride |
Cap 2 mg, 400 capsule, blister pack |
$7.05 |
$6.25 |
Diamide Relief (Mylan) |
1 July 2019 |
1 October 2019 |
|
Mercaptopurine1 |
Tab 50 mg, 25 tablet, bottle pack |
$49.41 |
$37.00 |
Puri-nethol (Aspen Pharma) |
1 April 2019 |
1 July 2019 |
|
Methyl hydroxybenzoate |
Powder, 25 g bottle |
$8.98 |
$8.98 |
Midwest |
1 April 2019 |
1 July 2019 |
|
Methylcellulose |
Powder, 100 g bottle |
$36.95 |
$36.95 |
Midwest |
1 April 2019 |
1 July 2019 |
|
Methylcellulose |
Suspension, 473 ml bottle |
$32.50 |
$30.95 |
Ora Plus (Midwest) |
1 April 2019 |
1 July 2019 |
|
Methylcellulose with glycerin and sodium saccharin |
Suspension, 473 ml bottle |
$32.50 |
$30.95 |
Ora Blend SF (Midwest) |
1 April 2019 |
1 July 2019 |
|
Methylcellulose with glycerin and sucrose suspension |
Suspension, 473 ml bottle |
$32.50 |
$30.95 |
Ora Blend |
1 April 2019 |
1 July 2019 |
|
Nortriptyline hydrochloride |
Tab 10 mg, 100 tablet, blister pack |
$3.22 |
$2.44 |
Norpress |
1 July 2019 |
1 October 2019 |
|
Nortriptyline hydrochloride |
Tab 25 mg, 180 tablet, blister pack |
$7.08 |
$5.98 |
Norpress |
1 July 2019 |
1 October 2019 |
|
Pantoprazole |
Tab EC 20 mg, 100 tablet, bottle pack |
$2.41 |
$2.02 |
Panzop Relief |
1 July 2019 |
1 October 2019 |
|
Pantoprazole |
Tab EC 40 mg, 100 tablet, bottle pack |
$3.35 |
$2.85 |
Panzop Relief |
1 July 2019 |
1 October 2019 |
|
Perhexiline maleate |
Tab 100 mg, 100 tablet, bottle pack |
$62.90 |
$62.90 |
Pexsig |
1 July 2019 |
1 October 2019 |
|
Pramipexole hydrochloride |
Tab 0.25 mg, 100 tablet, blister pack |
$7.20 |
$6.12 |
Ramipex (Deva Holdings) |
1 July 2019 |
1 October 2019 |
|
Pramipexole hydrochloride |
Tab 1 mg, 100 tablet, blister pack |
$24.39 |
$20.73 |
Ramipex (Deva Holdings) |
1 July 2019 |
1 October 2019 |
|
Risedronate sodium |
Tab 35 mg, 4 tablet, foil strip pack |
$3.80 |
$3.10 |
Risedronate Sandoz (Novartis) |
1 July 2019 |
1 October 2019 |
|
Sotalol |
Tab 80 mg, 500 tablet, bottle pack |
$39.53 |
$32.58 |
Mylan (Mylan) |
1 July 2019 |
1 October 2019 |
|
Sotalol |
Tab 160 mg, 100 tablet, bottle pack |
$12.48 |
$10.98 |
Mylan (Mylan) |
1 July 2019 |
1 October 2019 |
|
Sumatriptan |
Tab 50 mg, 100 tablet, blister pack |
$24.44 |
$24.44 |
Apo-Sumatriptan |
1 July 2019 |
1 October 2019 |
|
Sumatriptan |
Tab 100 mg, 100 tablet, blister pack |
$46.23 |
$46.23 |
Apo-Sumatriptan |
1 July 2019 |
1 October 2019 |
|
Tenoxicam |
Tab 20 mg, 100 tablet, blister pack |
$10.95 |
$9.15 |
Tilocotil (Mylan) |
1 July 2019 |
1 October 2019 |
|
Tetrabenazine |
Tab 25 mg, 112 tablet, bottle pack |
$91.10 |
$91.10 |
Motetis |
1 July 2019 |
1 October 2019 |
|
Zinc sulphate |
Cap 137.4 mg (50 mg elemental), 100 capsule, bottle pack |
$11.00 |
$11.00 |
Zincaps |
1 September |
1 December 2019 |
|
* These products will be supplied at the Price from the 22nd day of the month prior to the listing date, as per Schedule 5, clause 3.1 (b)(iv) of the 2018/19 Invitation To Tender. 1 Mercaptopurineis listed in Section B of the Pharmaceutical Schedule as a PCT only – Specialist pharmaceutical |
||||||
Hospital pharmaceutical tenders – Section H of the Pharmaceutical Schedule
2. Tenders awarded to currently listed pharmaceuticals where no other brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
Current |
New |
Hospital supply brand |
DV |
Listing date |
Hospital Supply Status date |
|---|---|---|---|---|---|---|---|
|
Aciclovir |
Tab dispersible 200 mg, 25 tablet, blister pack |
$1.60 |
$1.60 |
Lovir |
1% |
1 July 2019 |
1 October 2019 |
|
Aciclovir |
Tab dispersable 400 mg, 56 tablet blister pack |
$5.38 |
$5.38 |
Lovir |
1% |
1 July 2019 |
1 October 2019 |
|
Aciclovir |
Tab dispersible 800 mg, 35 tablet, blister pack |
$5.98 |
$5.98 |
Lovir |
1% |
1 July 2019 |
1 October 2019 |
|
Aspirin2 |
Tab 100 mg, 990 tablet, blister pack |
$12.50 |
$10.80 |
Ethics Aspirin EC (Multichem) |
10% |
1 August 2019 |
1 November 2019 |
|
Aspirin |
Tab dispersible 300 mg, 100 tablet, blister pack |
$3.90 |
$4.50 |
Ethics Aspirin (Multichem) |
1% |
1 July 2019 |
1 October 2019 |
|
Calcitriol |
Cap 0.5 mcg, 100 capsule, bottle pack |
$18.39 |
$13.75 |
Calcitriol-AFT |
1% |
1 July 2019 |
1 October 2019 |
|
Calcitriol |
cap 0.25 mcg, 100 capsule, bottle pack |
$9.95 |
$7.95 |
Calcitriol-AFT |
1% |
1 July 2019 |
1 October 2019 |
|
Cefaclor |
Cap 250 mg, 100 capsule, bottle pack |
$24.70 |
$24.70 |
Ranbaxy-Cefaclor |
1% |
1 July 2019 |
1 October 2019 |
|
Cefaclor |
Grans for oral liq 25 mg per ml, 100 ml bottle |
$3.53 |
$3.53 |
Ranbaxy-Cefaclor |
1% |
1 July 2019 |
1 October 2019 |
|
Chlortalidone [chlorthalidone] |
Tab 25 mg, 50 tablet, bottle pack |
$8.00 |
$6.50 |
Hygroton (AFT) |
1% |
1 September 2019 |
1 December 2019 |
|
Dimethicone |
Crm, 5% pump bottle, 500 ml |
$4.59 |
$4.48 |
HealthE Dimethicone 5% (Jaychem) |
1% |
1 July 2019 |
1 October 2019 |
|
Dimethicone |
Crm 5% tube, 100 g |
$1.59 |
$1.53 |
healthE Dimethicone 5% |
1% |
1 July 2019 |
1 October 2019 |
|
Dimethicone |
Lotn 4%, 200 ml |
$4.98 |
$4.98 |
healthE Dimethicone 4% Lotion |
1% |
1 July 2019 |
1 October 2019 |
|
Dipyridamole |
Tab long-acting 150 mg, 60 tablet, bottle pack |
$11.52 |
$10.90 |
Pytazen SR (Douglas) |
1% |
1 July 2019 |
1 October 2019 |
|
Ertapenem |
Inj 1 g vial, 1 vial pack |
$73.50 |
$70.00 |
Invanz |
1% |
1 May 2019 |
1 August 2019 |
|
Erythromycin (as lactobionate) |
Inj 1 g vial, 1 vial pack |
$16.00 |
$10.00 |
Erythromycin IV (AFT) |
1% |
1 September 2019 |
1 December 2019 |
|
Etoposide |
Cap 50 mg, 20 capsule, blister pack |
$340.73 |
$340.73 |
Vepesid |
1% |
1 April 2019 |
1 July 2019 |
|
Etoposide |
Cap 100 mg, 10 capsule, blister pack |
$340.73 |
$340.73 |
Vepesid |
1% |
1 April 2019 |
1 July 2019 |
|
Fluconazole |
Inj 2 mg per ml, 100 ml vial |
$6.47 |
$3.45 |
Fluconazole-Claris (Baxter) |
1% |
1 July 2019 |
1 October 2019 |
|
Fluconazole |
Inj 2 mg per ml, 50 ml vial |
$4.95 |
$2.80 |
Fluconazole-Claris (Baxter) |
1% |
1 July 2019 |
1 October 2019 |
|
Furosemide [frusemide] |
Inj 10 mg per ml, 2 ml ampoule, 5 glass ampoules |
$1.20 |
$1.15 |
Frusemide-Claris (Baxter) |
1% |
1 July 2019 |
1 October 2019 |
|
Glycerin with sodium saccharin |
Suspension, 473 ml bottle |
$32.50 |
$30.95 |
Ora-Sweet SF (Midwest) |
1% |
1 April 2019 |
1 July 2019 |
|
Glycerin with sucrose |
Suspension, 473 ml bottle |
$32.50 |
$30.95 |
Ora-Sweet (Midwest) |
1% |
1 April 2019 |
1 July 2019 |
|
Haloperidol |
Inj 5 mg per ml, 1 ml ampoule, 10 glass ampoules |
$21.55 |
$21.55 |
Serenace |
1% |
1 July 2019 |
1 October 2019 |
|
Haloperidol |
Oral liq 2 mg per ml, 100 ml bottle |
$23.84 |
$23.84 |
Serenace |
1% |
1 July 2019 |
1 October 2019 |
|
Haloperidol |
Tab 500 mcg, 100 tablet, bottle pack |
$6.23 |
$6.23 |
Serenace |
1% |
1 July 2019 |
1 October 2019 |
|
Haloperidol |
Tab 1.5 mg, 100 tablet, bottle pack |
$9.43 |
$9.43 |
Serenace |
1% |
1 July 2019 |
1 October 2019 |
|
Haloperidol |
Tab 5mg, 100 tablet, bottle pack |
$29.72 |
$29.72 |
Serenace |
1% |
1 July 2019 |
1 October 2019 |
|
Imipenem with cilastatin |
Inj 500 mg with cilastatin 500 mg vial, 1 vial pack |
$60.00 |
$60.00 |
Imipenem + Cilastatin RBX |
1% |
1 April 2019 |
1 July 2019 |
|
Levetiracetam |
Inj 100 mg per ml, 5 ml vial, 10 vials |
$52.68 |
$38.95 |
Levetiracetam-AFT |
1% |
1 July 2019 |
1 October 2019 |
|
Levetiracetam* |
Tab 250 mg, 60 tablet, blister pack |
$24.03 |
$4.99 |
Everet (Rex Medical) |
1% |
1 May 2019 |
1 August 2019 |
|
Levetiracetam* |
Tab 500 mg, 60 tablet, blister pack |
$28.71 |
$8.79 |
Everet (Rex Medical) |
1% |
1 May 2019 |
1 August 2019 |
|
Levetiracetam* |
Tab 750 mg, 60 tablet, blister pack |
$45.23 |
$14.39 |
Everet (Rex Medical) |
1% |
1 May 2019 |
1 August 2019 |
|
Levetiracetam* |
Tab 1,000 mg, 60 tablet, blister pack |
$59.12 |
$18.59 |
Everet (Rex Medical) |
1% |
1 May 2019 |
1 August 2019 |
|
Lidocaine [lignocaine] hydrochloride |
Inj 1%, 20 ml vial, 5 vials |
$12.00 |
$6.20 |
Lidocaine-Claris (Baxter) |
1% |
1 April 2019 |
1 July 2019 |
|
Lidocaine [lignocaine] hydrochloride |
Inj 2%, 20 ml vial, 5 vials |
$12.00 |
$6.45 |
Lidocaine-Claris (Baxter) |
1% |
1 April 2019 |
1 July 2019 |
|
Lidocaine [lignocaine] hydrochloride |
Spray 10 %, 50 ml, spray bottle |
$75.00 |
$75.00 |
Xylocaine |
1% |
1 April 2019 |
1 July 2019 |
|
Loperamide hydrochloride |
Cap 2 mg, 400 capsule, blister pack |
$7.05 |
$6.25 |
Diamide Relief (Mylan) |
1% |
1 July 2019 |
1 October 2019 |
|
Mercaptopurine |
Tab 50 mg, 25 tablet, bottle pack |
$49.41 |
$37.00 |
Puri-nethol (Aspen Pharma) |
1% |
1 April 2019 |
1 July 2019 |
|
Methylcellulose |
Suspension, 473 ml bottle |
$32.50 |
$30.95 |
Ora Plus (Midwest) |
1% |
1 April 2019 |
1 July 2019 |
|
Methylcellulose with glycerin and sodium saccharin |
Suspension, 473 ml bottle |
$32.50 |
$30.95 |
Ora Blend SF (Midwest) |
1% |
1 April 2019 |
1 July 2019 |
|
Methylcellulose with glycerin and sucrose suspension |
Suspension, 473 ml bottle |
$32.50 |
$30.95 |
Ora Blend (Midwest) |
1% |
1 April 2019 |
1 July 2019 |
|
Noradrenaline |
Inj 1 mg per ml, 4 ml ampoule, 10 ampoules |
$125.00 |
$45.00 |
Noradrenaline BNM |
1% |
1 July 2019 |
1 October 2019 |
|
Nortriptyline hydrochloride |
Tab 10 mg, 100 tablet, blister pack |
$3.22 |
$2.44 |
Norpress (Mylan) |
1% |
1 July 2019 |
1 October 2019 |
|
Nortriptyline hydrochloride |
Tab 25 mg, 180 tablet, blister pack |
$7.08 |
$5.98 |
Norpress (Mylan) |
1% |
1 July 2019 |
1 October 2019 |
|
Omeprazole |
Inj 40 mg vial, 5 vials |
$13.00 |
$11.46 |
Omezol IV (Mylan) |
1% |
1 July 2019 |
1 October 2019 |
|
Pantoprazole |
Tab EC 20 mg, 100 tablet, bottle pack |
$2.41 |
$2.02 |
Panzop Relief (Mylan) |
1% |
1 July 2019 |
1 October 2019 |
|
Pantoprazole |
Tab EC 40 mg, 100 tablet, bottle pack |
$3.35 |
$2.85 |
Panzop Relief (Mylan) |
1% |
1 July 2019 |
1 October 2019 |
|
Perhexiline maleate |
Tab 100 mg, 100 tablet, bottle pack |
$62.90 |
$62.90 |
Pexsig |
1% |
1 July 2019 |
1 October 2019 |
|
Pramipexole hydrochloride |
Tab 0.25 mg, 100 tablet, blister pack |
$7.20 |
$6.12 |
Ramipex (Deva Holdings) |
1% |
1 July 2019 |
1 October 2019 |
|
Pramipexole hydrochloride |
Tab 1 mg, 100 tablet, blister pack |
$24.39 |
$20.73 |
Ramipex (Deva Holdings) |
1% |
1 July 2019 |
1 October 2019 |
|
Propofol |
Inj 10 mg per ml, 100 ml vial, 10 vials |
$49.00 |
$39.00 |
Fresofol 1% MCT/LCT (Fresenius Kabi) |
10% |
1 July 2019 |
1 October 2019 |
|
Propofol |
Inj 10 mg per ml, 50 ml vial , 10 vials |
$24.50 |
$19.50 |
Fresofol 1% MCT/LCT (Fresenius Kabi) |
10% |
1 July 2019 |
1 October 2019 |
|
Risedronate sodium |
Tab 35 mg, 4 tablet, foil strip pack |
$3.80 |
$3.10 |
Risedronate Sandoz (Novartis) |
1% |
1 July 2019 |
1 October 2019 |
|
Sotalol |
Tab 80 mg, 500 tablet, bottle pack |
$39.53 |
$32.58 |
Mylan (Mylan) |
1% |
1 July 2019 |
1 October 2019 |
|
Sotalol |
Tab 160 mg, 100 tablet, bottle pack |
$12.48 |
$10.98 |
Mylan (Mylan) |
1% |
1 July 2019 |
1 October 2019 |
|
Sumatriptan |
Tab 50 mg, 100 tablet, blister pack |
$24.44 |
$24.44 |
Apo-Sumatriptan |
1% |
1 July 2019 |
1 October 2019 |
|
Sumatriptan |
Tab 100 mg, 100 tablet, blister pack |
$46.23 |
$46.23 |
Apo-Sumatriptan |
1% |
1 July 2019 |
1 October 2019 |
|
Tenoxicam |
Tab 20 mg, 100 tablet, blister pack |
$10.95 |
$9.15 |
Tilocotil (Mylan) |
1% |
1 July 2019 |
1 October 2019 |
|
Tetrabenazine |
Tab 25 mg, 112 tablet, bottle pack |
$91.10 |
$91.10 |
Motetis |
1% |
1 July 2019 |
1 October 2019 |
|
Zinc sulphate |
Cap 137.4 mg (50 mg elemental), 100 capsule, bottle pack |
$11.00 |
$11.00 |
Zincaps |
1% |
1 September |
1 December 2019 |
|
2 The 90 pack size will remain listed and the 10% DV limit will apply to this pack size also * These products will be supplied at the Price from the 22nd day of the month prior to the listing date, as per Schedule 5, clause 3.1 (b)(iv) of the 2018/19 Invitation To Tender. |
|||||||
3. Tenders awarded to pharmaceuticals where no brand is listed.
The decisions were as follows:
|
Chemical name |
Presentation; |
New |
Hospital supply brand |
DV |
Listing date |
Hospital Supply Status date |
|---|---|---|---|---|---|---|
|
Methyl hydroxybenzoate |
Powder, 25 g bottle |
$8.98 |
Midwest |
1% |
1 April 2019 |
1 September 2019 |
|
Methylcellulose |
Powder, 100 g bottle |
$36.95 |
Midwest |
1% |
1 April 2019 |
1 September 2019 |
Tender declines - Products where no tender is to be awarded for Sole Subsidised Supply Status or Hospital Supply Status
PHARMAC has resolved not to award tenders for Sole Subsidised Supply Status or Hospital Supply Status for the following products listed in:
- the 2017/18 Invitation to Tender, dated 2 November 2017, and
- the 2018/19 Invitation to Tender, dated 1 November 2018
2017/18 Invitation to Tender
|
Chemical name |
Line item |
|---|---|
|
Febuxostat |
Tab 80 mg |
|
Febuxostat |
Tab 120 mg |
2018/19 Invitation to Tender
|
Chemical name |
Line item |
|---|---|
|
Acetylcholine chloride |
Inj 20 mg vial with diluent |
|
Amphotericin B |
Liposomal inj 50 mg |
|
Betamethasone Sodium Phosphate with Betamethasone Acetate |
Inj 3.9 mg with betamethasone acetate 3 mg per ml, 1ml |
|
Bupivacaine hydrochloride |
Inj 1.25 mg per ml, 500ml bag |
|
Bupivacaine hydrochloride |
Inj 1.25 mg per ml, 100 ml bag |
|
Bupivacaine hydrochloride |
Inj 2.5 mg per ml, 200 ml bag |
|
Calcium Gluconate |
Gel 2.5% |
|
Carboprost |
Inj 250 mcg per ml, 1ml |
|
Chlorpheniramine Maleate |
Inj 10 mg per ml |
|
Chlorpheniramine Maleate |
Oral liq 2 mg per 5 ml |
|
Clarithromycin |
Grans for oral liq 250 mg per 5 ml |
|
Diflucortolone Valerate |
Crm 0.1% |
|
Diflucortolone Valerate |
Fatty oint 0.1% |
|
Disulfiram |
Tab 200 mg |
|
Edrophonium chloride |
Inj 10 mg per ml, 1 ml |
|
Edrophonium chloride |
Inj 10 mg per ml, 15 ml |
|
Ethinyloestradiol with Desogestrel |
Tab 20 mcg with desogestrel 150 mcg |
|
Ethinyloestradiol with Desogestrel |
Tab 30 mcg with desogestrel 150 mcg |
|
Ethinyloestradiol with Norethisterone |
Tab 35 mcg with norethisterone 500 mcg |
|
Gemfibrozil |
Tab 600 mg |
|
Glyceryl trinitrate |
Patch 50 mg, 10 mg per day |
|
Glyceryl trinitrate |
Tab 600 mcg |
|
Glyceryl trinitrate |
Patch 25 mg, 5 mg per day |
|
Hyoscine hydrobromide |
Inj 400 mcg per ml, 1 ml |
|
Ketamine |
Inj 4 mg per ml, 50 ml syringe |
|
Lidocaine [lignocaine] hydrochloride with adrenaline |
Inj 1% with adrenaline 1:200,000, 20 ml |
|
Lidocaine [lignocaine] hydrochloride with adrenaline |
Inj 2% with adrenaline 1:200,000, 20 ml |
|
Medroxyprogesterone acetate |
Tab 100 mg |
|
Medroxyprogesterone acetate |
Tab 2.5 mg |
|
Medroxyprogesterone acetate |
Tab 5 mg |
|
Medroxyprogesterone acetate |
Tab 10 mg |
|
Metoclopramide hydrochloride |
Oral liq 5 mg per 5 ml |
|
Mifepristone |
Tab 200 mg |
|
Nicotine |
Oral spray 1 mg per dose |
|
Nicotine |
Soln for inhalation 15 mg cartridge |
|
Nitrofurantoin |
Modified-release 100 mg |
|
Norfloxacin |
Tab 400 mg |
|
Pancreatic enzyme |
Cap pancreatin (175 mg (25,000 lipase, 22,500 U amylase, 1,250 U protease)) |
|
Pancreatic enzyme |
Powder pancreatin 60.12 mg (3,600 Ph. Eur. u/amylase, 5,000 Ph. Eur. u/lipase and 200 Ph. Eur/protease) |
|
Paromomycin |
Cap 250 mg |
|
Phentolamine mesylate |
Inj 5 mg per ml, 1 ml |
|
Pivmecillinam |
Tab 200 mg |
|
Povidone Iodine |
Skin preparation, povidone iodine 10% with 30% alcohol (pack size 100 ml or less) |
|
Povidone Iodine |
Skin preparation, povidone iodine 10% with 30% alcohol (pack size greater than 100 ml) |
|
Protionamide |
Tab 250 mg |
|
Rasburicase |
Inj 1.5 mg |
|
Retinol palmitate |
Eye oint 138 mcg per g |
|
Salicylic Acid |
Powder |
|
Sodium alginate with sodium bicarbonate and calcium carbonate |
Tab 500 mg with sodium bicarbonate 267 mg and calcium carbonate 160 mg |
|
Sodium hyaluronate [hyaluronic acid] with chondroitin sulphate |
Inj 30 mg with chondroitin sulphate 40 mg per ml, 0.75 ml syringe |
|
Thymol glycerin |
Compound, BPC |
|
Trimethoprim with sulphamethoxazole [Co-trimoxazole] |
Tab trimethoprim 80 mg - 160 mg and sulphamethoxazole 400 mg - 800 mg |
|
Vincristine sulphate |
Inj 1 mg per ml, 1 - 2 ml |
|
Zuclopenthixol Decanoate |
Inj 200 mg per ml |
|
Zuclopenthixol decanoate |
Inj 500 mg per ml |
For products included in the 2016/17 and 2017/18 Invitation to Tender where no announcement has yet been made, either a decision is still pending or is provisional, subject to the product gaining market approval and being available to supply, and subject to PHARMAC Board (or its delegate) approval. We will keep you informed of any updates regarding such tender products as decisions are made.
If you have any queries regarding this notification, please contact PHARMAC on 0800 66 00 50.